ArticleBioengineering (Basel, Switzerland)2026
First Report of
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spontaneous fermentation of sugarcane juice for the production of artisanal sugarcane spirits in the Ecuadorian Amazon is driven by native microbial communities; however, the yeast diversity involved in this process remains poorly characterized. In this descriptive case study, sugarcane juice samples were collected from a single artisanal distillery at three fermentation stages (0, 48, and 96 h). Yeasts were isolated using selective culture techniques, yielding three distinct morphotypes (Y01, Y02, and Y03). A progressive reduction in morphological diversity was observed during fermentation, with isolate Y01 persisting at the final stage (96 h). Differences in crystal violet staining indicated variability in cellular metabolic activity among the isolates under the conditions tested. Biochemical characterization using the API 20C AUX system, combined with molecular identification based on ITS rDNA sequencing, was performed for isolate Y01, which showed ≥99% sequence identity with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.